“The test already has the ability to predict the onset of the condition up to four years in advance, however the collaborative study with Janssen Research and Development has extended the potential use of the test to predict further decline in renal function among people who already have kidney disease.“
“This exploratory data is promising and indicates the use of PromarkerD may be expanded to include people with existing kidney disease…… The results also suggested further studies were warranted to explore whether PromarkerD could predict additional cardiovascular outcomes, such as heart failure and stroke. – Proteomics International Laboratories Managing Director, Dr Richard Lipscombe“
